About Panorad AISee Risk Before You Invest.
Panorad AI is the decision-intelligence platform that simulates clinical, regulatory, and market outcomes across the biotech lifecycle.
Our Outcome Simulator models phase-specific probabilities, tail risk, program dependencies, and commercial upside — before capital is deployed.
Our secure, in-tenant platform connects internal data, trial results, KOL insights, and real-world signals to:
- Identify hidden failure risks early
- Prioritize programs with the highest probability-weighted value
- Accelerate diligence and eliminate surprises post-invest
Fund managers already look to us to deliver fast, explainable conviction on complex scientific bets.
The OpportunityWe are adding one biotech-specialized Strategic Advisory Partner to drive adoption among:
- Biotech funds and crossover investors
- Pharma corporate development teams
- Hedge fund biotech PMs
- Life sciences risk and diligence consultants
You’ll bring the network.
We’ll bring the technology that makes them faster and smarter.
This is fractional.
High-leverage.
Outcome-linked upside.
Why This Vertical Matters
Biotech is uncertainty.
Clinical risk
Regulatory risk
Pipeline timing risk
Capital runway risk
Competition and market access surprises
A single blind spot can wipe a fund year.
Panorad AI makes that visible before decisions are locked:
- Phase transition forecasting
- Mechanism-of-action risk mapping
- Competitive pipeline stress tests
- Regulatory pathway scenario simulation
- Probability-weighted valuation deltas
Give decision-makers confidence backed by evidence.
What You Will Do- Generate warm intros to biotech decision-makers (funds, BD&L leaders, PMs)
- Guide a 30-day simulation pilot on active or recent programs/portfolio
- Pressure-test positioning and outcome metrics for scientific audiences
- Support creation of case studies proving predictive insight and ROI
You help secure one high-conviction design partner.
We handle delivery and execution.
Ideal Partner ProfileYou Are:
- A seasoned biotech investor, PM, Corp Dev leader, or consulting partner
- Trusted by those deploying capital into clinical science
- Fluent in the language of MOA, endpoints, indication fit, trial design, market access
- Wired to move quickly when a better way presents itself
Your Network Includes:
- Biotech funds managing $50M–$2B AUM
- Pharma BD&L and external innovation decision-makers
- Risk & diligence consultants inside leading life-science advisories
Strategic UpsideFor You
- Equity tied to measurable impact
- Access to a tool that enhances your own deal decisions
- Be early in defining how biotech capital allocators evaluate risk
For Panorad
- Category leadership in the most risk-sensitive investment market
- Industry validation by those who shape biotech decision frameworks
- Accelerated channel expansion into clinical-stage capital
What Success Looks Like in 60 Days
- 10+ qualified biotech investor intros
- 1–2 pilots analyzing live or historical programs
- Measurable lift in decision speed and predictive accuracy
- First case study with LP-quality evidence
Location: Bay Area preferred (Remote OK)
Engagement: Fractional | Outcome-based Upside
Timing: Immediate for the right partner
Use Panorad AI to See The Risk Before Investing In Biotech.
